Medpace Price to Sales Ratio vs Accounts Payable Analysis

MEDP Stock  USD 403.27  0.52  0.13%   
Medpace Holdings financial indicator trend analysis is infinitely more than just investigating Medpace Holdings recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Medpace Holdings is a good investment. Please check the relationship between Medpace Holdings Price To Sales Ratio and its Accounts Payable accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medpace Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.

Price To Sales Ratio vs Accounts Payable

Price to Sales Ratio vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Medpace Holdings Price to Sales Ratio account and Accounts Payable. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Medpace Holdings' Price to Sales Ratio and Accounts Payable is 0.56. Overlapping area represents the amount of variation of Price to Sales Ratio that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Medpace Holdings, assuming nothing else is changed. The correlation between historical values of Medpace Holdings' Price to Sales Ratio and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price to Sales Ratio of Medpace Holdings are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Price to Sales Ratio i.e., Medpace Holdings' Price to Sales Ratio and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.56
Relationship DirectionPositive 
Relationship StrengthWeak

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Medpace Holdings stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Medpace Holdings sales, a figure that is much harder to manipulate than other Medpace Holdings multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.

Accounts Payable

An accounting item on the balance sheet that represents Medpace Holdings obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Medpace Holdings are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Medpace Holdings' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Medpace Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medpace Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.As of 03/28/2024, Selling General Administrative is likely to drop to about 95.9 M. In addition to that, Tax Provision is likely to drop to about 24.3 M
 2021 2022 2023 2024 (projected)
Gross Profit328.2M432.4M524.5M278.6M
Total Revenue1.1B1.5B1.9B2.0B

Medpace Holdings fundamental ratios Correlations

-0.430.2-0.24-0.69-0.030.260.16-0.42-0.690.250.52-0.37-0.12-0.53-0.7-0.460.31-0.12-0.50.710.510.330.220.33-0.43
-0.43-0.390.060.790.54-0.310.420.910.81-0.69-0.020.740.850.670.80.74-0.50.850.81-0.42-0.32-0.45-0.42-0.450.84
0.2-0.39-0.01-0.58-0.750.84-0.8-0.59-0.580.90.04-0.8-0.440.31-0.51-0.510.98-0.44-0.670.35-0.40.731.00.73-0.69
-0.240.06-0.010.34-0.37-0.12-0.20.320.30.14-0.710.32-0.310.320.340.19-0.13-0.310.31-0.01-0.18-0.11-0.09-0.110.38
-0.690.79-0.580.340.38-0.570.260.861.0-0.68-0.50.850.490.540.990.79-0.710.490.89-0.77-0.43-0.57-0.62-0.570.88
-0.030.54-0.75-0.370.38-0.560.920.50.4-0.910.530.560.83-0.190.350.47-0.720.830.41-0.220.46-0.58-0.73-0.580.5
0.26-0.310.84-0.12-0.57-0.56-0.58-0.48-0.570.740.2-0.65-0.310.23-0.55-0.340.86-0.31-0.570.45-0.310.580.840.58-0.58
0.160.42-0.8-0.20.260.92-0.580.50.28-0.860.490.610.7-0.360.210.39-0.750.70.420.060.63-0.59-0.79-0.590.52
-0.420.91-0.590.320.860.5-0.480.50.87-0.74-0.240.930.690.520.830.83-0.70.690.94-0.38-0.21-0.56-0.63-0.570.98
-0.690.81-0.580.31.00.4-0.570.280.87-0.7-0.470.850.520.550.990.79-0.710.520.89-0.77-0.43-0.57-0.62-0.570.88
0.25-0.690.90.14-0.68-0.910.74-0.86-0.74-0.7-0.16-0.82-0.780.03-0.64-0.660.91-0.78-0.720.43-0.250.710.890.71-0.76
0.52-0.020.04-0.71-0.50.530.20.49-0.24-0.47-0.16-0.30.46-0.36-0.49-0.230.150.46-0.40.460.550.140.090.14-0.32
-0.370.74-0.80.320.850.56-0.650.610.930.85-0.82-0.30.570.230.80.78-0.880.570.95-0.4-0.05-0.7-0.84-0.70.97
-0.120.85-0.44-0.310.490.83-0.310.70.690.52-0.780.460.570.310.50.57-0.481.00.53-0.220.06-0.42-0.44-0.420.61
-0.530.670.310.320.54-0.190.23-0.360.520.550.03-0.360.230.310.60.450.150.310.42-0.38-0.780.040.270.040.41
-0.70.8-0.510.340.990.35-0.550.210.830.99-0.64-0.490.80.50.60.71-0.650.50.87-0.77-0.47-0.54-0.55-0.540.86
-0.460.74-0.510.190.790.47-0.340.390.830.79-0.66-0.230.780.570.450.71-0.620.570.72-0.53-0.25-0.51-0.54-0.510.76
0.31-0.50.98-0.13-0.71-0.720.86-0.75-0.7-0.710.910.15-0.88-0.480.15-0.65-0.62-0.48-0.770.44-0.280.780.990.78-0.79
-0.120.85-0.44-0.310.490.83-0.310.70.690.52-0.780.460.571.00.310.50.57-0.480.53-0.220.06-0.42-0.44-0.420.61
-0.50.81-0.670.310.890.41-0.570.420.940.89-0.72-0.40.950.530.420.870.72-0.770.53-0.46-0.25-0.62-0.71-0.620.97
0.71-0.420.35-0.01-0.77-0.220.450.06-0.38-0.770.430.46-0.4-0.22-0.38-0.77-0.530.44-0.22-0.460.50.310.350.31-0.39
0.51-0.32-0.4-0.18-0.430.46-0.310.63-0.21-0.43-0.250.55-0.050.06-0.78-0.47-0.25-0.280.06-0.250.5-0.21-0.37-0.21-0.16
0.33-0.450.73-0.11-0.57-0.580.58-0.59-0.56-0.570.710.14-0.7-0.420.04-0.54-0.510.78-0.42-0.620.31-0.210.741.0-0.66
0.22-0.421.0-0.09-0.62-0.730.84-0.79-0.63-0.620.890.09-0.84-0.440.27-0.55-0.540.99-0.44-0.710.35-0.370.740.74-0.73
0.33-0.450.73-0.11-0.57-0.580.58-0.59-0.57-0.570.710.14-0.7-0.420.04-0.54-0.510.78-0.42-0.620.31-0.211.00.74-0.66
-0.430.84-0.690.380.880.5-0.580.520.980.88-0.76-0.320.970.610.410.860.76-0.790.610.97-0.39-0.16-0.66-0.73-0.66
Click cells to compare fundamentals

Medpace Holdings Account Relationship Matchups

Medpace Holdings fundamental ratios Accounts

201920202021202220232024 (projected)
Common Stock Shares Outstanding37.6M37.7M37.7M33.7M31.8M29.1M
Total Assets1.1B1.4B1.7B1.4B1.7B1.3B
Short Long Term Debt Total45.2M115.1M131.0M188.9M142.1M156.5M
Other Current Liab19.0M23.5M27.6M257.7M40.4M70.6M
Total Current Liabilities343.0M440.1M557.2M803.5M925.1M971.4M
Total Stockholder Equity726.3M805.8M952.9M386.4M559.0M654.5M
Other Liab28.6M29.6M18.8M23.8M21.4M20.0M
Net Tangible Assets9.5M96.9M249.2M(314.0M)(361.1M)(379.2M)
Property Plant And Equipment Net99.4M198.8M222.7M248.9M265.4M138.1M
Current Deferred Revenue192.4M255.7M344.6M462.7M559.9M587.9M
Net Debt(86.7M)(162.6M)(330.3M)160.6M(103.3M)(98.2M)
Retained Earnings68.1M115.2M235.0M(359.8M)(221.6M)(210.6M)
Accounts Payable22.4M26.6M25.7M33.1M31.9M21.9M
Cash131.9M277.8M461.3M28.3M245.4M143.1M
Non Current Assets Total826.0M917.0M969.0M1.0B1.1B1.0B
Non Currrent Assets Other9.5M8.8M17.4M21.1M25.0M26.2M
Other Assets9.9M123.1M42.6M69.2M79.6M83.6M
Cash And Short Term Investments131.9M277.8M461.3M28.3M245.4M143.1M
Net Receivables155.7M161.0M186.4M253.4M298.4M163.0M
Common Stock Total Equity355K356K360K309K278.1K279.2K
Liabilities And Stockholders Equity1.1B1.4B1.7B1.4B1.7B1.3B
Non Current Liabilities Total73.8M144.8M149.8M162.6M172.7M182.2M
Other Current Assets29.4M34.9M43.2M52.3M50.0M32.1M
Other Stockholder Equity660.6M690.3M722.4M758.3M790.4M699.5M
Total Liab416.8M584.9M707.0M966.1M1.1B685.5M
Deferred Long Term Liab12.8M13.6M1.1M1.1M1.2M1.2M
Property Plant And Equipment Gross99.4M198.8M222.7M248.9M344.8M362.0M
Total Current Assets317.0M473.7M690.9M334.0M593.8M338.7M
Accumulated Other Comprehensive Income(2.7M)(131K)(4.8M)(12.4M)(10.1M)(9.6M)
Short Term Debt109.3M134.4M159.3M50M293.0M307.6M
Intangible Assets54.4M46.5M41.4M38.0M35.8M34.0M
Common Stock355K356K360K309K308K275.9K
Property Plant Equipment99.4M85.0M93.2M109.8M126.3M74.3M
Capital Surpluse666.6M695.9M727.9M770.8M886.4M714.1M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Medpace Holdings is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Medpace Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Medpace Holdings Stock. Highlighted below are key reports to facilitate an investment decision about Medpace Holdings Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medpace Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.
Note that the Medpace Holdings information on this page should be used as a complementary analysis to other Medpace Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Complementary Tools for Medpace Stock analysis

When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Is Medpace Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medpace Holdings. If investors know Medpace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medpace Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.165
Earnings Share
8.86
Revenue Per Share
61.384
Quarterly Revenue Growth
0.265
Return On Assets
0.1399
The market value of Medpace Holdings is measured differently than its book value, which is the value of Medpace that is recorded on the company's balance sheet. Investors also form their own opinion of Medpace Holdings' value that differs from its market value or its book value, called intrinsic value, which is Medpace Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medpace Holdings' market value can be influenced by many factors that don't directly affect Medpace Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medpace Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Medpace Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medpace Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.